Verdinexor
Verdinexor (KPT-335) is an orally bioavailable, selective inhibitor of the nuclear export protein XPO1/CRM1. It is utilized in preclinical research to study oncology, virology, and inflammation, demonstrating activity in both cellular assays and animal models of cancer and viral infection.
Product Specifications
CAS Number
1392136-43-4
Product Name Alternative
CRM1, KPT335, KPT-335, KPT 335, Verdinexor
Field of Research
Cell Biology, Infectious Disease & Virology, Pharmacology & Drug Discovery
Purity
98.00% (May vary between batches)
Solubility
DMSO:82 mg/mL (185.39 mM) ; Ethanol:9 mg/mL (20.35 mM) ;10% DMSO+40% PEG300+5% Tween 80+45% Saline:3.3 mg/mL (7.46 mM)
Smiles
FC (F) (F) c1cc (cc (c1) C (F) (F) F) -c1ncn (\C=C/C (=O) NNc2ccccn2) n1
Molecular Formula
C18H12F6N6O
Molecular Weight
442.32
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
GTR15082897 1 Vial
Lentiviral human HS6ST1 shRNA (UAS) - Lentiviral human HS6ST1 shRNA (UAS, RFP) plasmid
Sign In for Pricing
View Details 
